Embodiments of the invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation in mammals, including humans, by administering compositions comprising i) an effective amount of an analgesic having an optional anti-inflammatory effect (ii) an amount of caffeine effective in enhancement of pain relief and, (iii) an amount of B vitamins effective in enhancement of pain relief.
